| Health / Medical Topics |
RG7204
A drug used to treat advanced melanoma that has a mutated (changed) form of a cell protein called BRAF. It is also being studied in the treatment of other types of cancer. RG7204 blocks this mutated protein, which may stop the growth of cancer cells. It is a type of kinase inhibitor and a type of targeted therapy agent. Also called BRAF (V600E) kinase inhibitor RO5185426, PLX4032, vemurafenib, and Zelboraf. (NCI Dictionary)
YOU MAY ALSO LIKE
A non-phenolic tyrphostin-class tyrosine kinase inhibitor that inhibits epidermal growth factor receptor, affecting cell proliferation and tumor growth in vivo.
A tyrosine kinase inhibitor that selectively inhibits epidermal growth factor receptor, epidermal factor-stimulated HER14 cell proliferation, and tumor growth in vivo. …
A 5-hydroxytryptamine-3 (5-HT3) receptor antagonist with antiemetic activity. RG 12915 binds to and antagonizes the action of serotonin on the 5-HT-3 receptor…
A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of melanoma that has spread to distant…
In cancer, the length of time after primary treatment for a cancer ends that the patient survives without any signs or symptoms…
A cancer vaccine made with a form of a chicken virus that does not cause disease in humans. It is being studied…
